Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study of Azenosertib and Niraparib for Patients with Platinum-Resistant Ovarian Cancer
FranceStudy on Avelumab for Patients with Advanced or Metastatic Squamous Cell Penile Cancer After Initial Chemotherapy
FranceStudy on Mesalamine to Prevent Colorectal Cancer in Patients with Lynch Syndrome
DenmarkStudy of Gandotinib for Patients with Myeloproliferative Neoplasms, Myelofibrosis, Essential Thrombocythemia, or Polycythemia Vera
AustriaStudy Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
BelgiumStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
CroatiaStudy on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer
AustriaStudy of Pembrolizumab and Lenvatinib for Patients with Classic Kaposi Sarcoma After Previous Treatment
ItalyStudy on the Effects of XP-DC+TL+KLH in Patients with Ovarian Cancer Undergoing Chemotherapy
The NetherlandsStudy on the Safety and Effectiveness of Domvanalimab, Zimberelimab, and Quemliclustat in Adults with Advanced Upper Gastrointestinal Cancer
FranceStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
CzechiaStudy on the Effectiveness and Safety of Ibrutinib with Rituximab-CHOP for Untreated Patients with Diffuse Large B-cell Lymphoma at High Risk
ItalyThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
